Affymetrix quarterly sales top $100m:
This article was originally published in Clinica
Executive Summary
Microarray market leader Affymetrix said that its preliminary financial data for the fourth quarter of financial 2004 indicated product and product-related revenues will exceed $100m for the first time in its 12-year history. In 2003 the Santa Clara, California company went into the black for the first time, reporting a net income of $14.3m on sales of $301m, 93% of which were product and product-related.